Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Multiple Sclerosis Therapies Market, by Type, 2018-2027 (USD Billion)
1.2.2. Multiple Sclerosis Therapies Market, by Route of Administration, 2018-2027 (USD Billion)
1.2.3. Multiple Sclerosis Therapies Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Multiple Sclerosis Therapies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Multiple Sclerosis Therapies Market Dynamics
3.1. Multiple Sclerosis Therapies Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Multiple Sclerosis Therapies Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Multiple Sclerosis Therapies Market, by Type
5.1. Market Snapshot
5.2. Global Multiple Sclerosis Therapies Market by Source, Performance - Potential Analysis
5.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis
5.4.1. Immunosuppressants
5.4.2. Immunomodulators
Chapter 6. Global Multiple Sclerosis Therapies Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Multiple Sclerosis Therapies Market by Source, Performance - Potential Analysis
6.3. Global Multiple Sclerosis Therapies Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
6.4. Multiple Sclerosis Therapies Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Intravenous
Chapter 7. Global Multiple Sclerosis Therapies Market, Regional Analysis
7.1. Multiple Sclerosis Therapies Market, Regional Market Snapshot
7.2. North America Multiple Sclerosis Therapies Market
7.2.1. U.S. Multiple Sclerosis Therapies Market
7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Multiple Sclerosis Therapies Market
7.3. Europe Multiple Sclerosis Therapies Market Snapshot
7.3.1. U.K. Multiple Sclerosis Therapies Market
7.3.2. Germany Multiple Sclerosis Therapies Market
7.3.3. France Multiple Sclerosis Therapies Market
7.3.4. Spain Multiple Sclerosis Therapies Market
7.3.5. Italy Multiple Sclerosis Therapies Market
7.3.6. Rest of Europe Multiple Sclerosis Therapies Market
7.4. Asia-Pacific Multiple Sclerosis Therapies Market Snapshot
7.4.1. China Multiple Sclerosis Therapies Market
7.4.2. India Multiple Sclerosis Therapies Market
7.4.3. Japan Multiple Sclerosis Therapies Market
7.4.4. Australia Multiple Sclerosis Therapies Market
7.5. Latin America Multiple Sclerosis Therapies Market Snapshot
7.6. Rest of The World Multiple Sclerosis Therapies Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Abbvie Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer AG
8.2.3. Biogen
8.2.4. Bristol-Myers Squibb Company
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.6. Merck KGAA
8.2.7. Novartis AG
8.2.8. Pfizer Inc.
8.2.9. Sanofi
8.2.10. Teva Pharmaceutical Industries Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption